Nu Skin Enterprises, Inc. (NYSE: NUS) Stock Competitors & Peer Comparison
See NUS's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NUS and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NUS | $4.53 | -1.31% | 219.9M | 3.78 | $1.20 | +5.28% |
| PG | $145.28 | -2.05% | 345.5B | 20.94 | $6.94 | +2.94% |
| UL | $60.73 | -0.83% | 130.9B | 20.25 | $3.00 | +3.64% |
| CL | $85.32 | -1.32% | 68.3B | 22.75 | $3.75 | +2.44% |
| KVUE | $17.66 | -1.40% | 33.9B | 14.97 | $1.18 | +5.87% |
| EL | $92.77 | -1.70% | 33.6B | 42.00 | $2.21 | +1.49% |
| KMB | $97.43 | -1.58% | 32.3B | 13.08 | $7.45 | +5.20% |
| CHD | $94.22 | -0.77% | 22.3B | 26.47 | $3.56 | +1.28% |
| CLX | $81.01 | -0.72% | 9.8B | 14.62 | $5.54 | +6.09% |
| ELF | $100.97 | -0.72% | 5.9B | 25.30 | $3.99 | N/A |
Stock Comparison
The Procter & Gamble Company (NYSE: PG)
NUS vs PG Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, PG has a market cap of 345.5B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while PG trades at $145.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas PG's P/E ratio is 20.94. In terms of profitability, NUS's ROE is -0.29%, compared to PG's ROE of +0.30%. Regarding short-term risk, NUS is more volatile compared to PG. This indicates higher risk in terms of short-term price fluctuations for NUS.Check PG's competition here
Unilever PLC (NYSE: UL)
NUS vs UL Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, UL has a market cap of 130.9B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while UL trades at $60.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas UL's P/E ratio is 20.25. In terms of profitability, NUS's ROE is -0.29%, compared to UL's ROE of +0.37%. Regarding short-term risk, NUS is more volatile compared to UL. This indicates higher risk in terms of short-term price fluctuations for NUS.Check UL's competition here
Colgate-Palmolive Company (NYSE: CL)
NUS vs CL Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, CL has a market cap of 68.3B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while CL trades at $85.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas CL's P/E ratio is 22.75. In terms of profitability, NUS's ROE is -0.29%, compared to CL's ROE of +6.31%. Regarding short-term risk, NUS is more volatile compared to CL. This indicates higher risk in terms of short-term price fluctuations for NUS.Check CL's competition here
Kenvue Inc. (NYSE: KVUE)
NUS vs KVUE Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, KVUE has a market cap of 33.9B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while KVUE trades at $17.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas KVUE's P/E ratio is 14.97. In terms of profitability, NUS's ROE is -0.29%, compared to KVUE's ROE of +0.16%. Regarding short-term risk, NUS is more volatile compared to KVUE. This indicates higher risk in terms of short-term price fluctuations for NUS.Check KVUE's competition here
The Estée Lauder Companies Inc. (NYSE: EL)
NUS vs EL Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, EL has a market cap of 33.6B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while EL trades at $92.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas EL's P/E ratio is 42.00. In terms of profitability, NUS's ROE is -0.29%, compared to EL's ROE of +0.05%. Regarding short-term risk, NUS is less volatile compared to EL. This indicates lower risk in terms of short-term price fluctuations for NUS.Check EL's competition here
Kimberly-Clark Corporation (NASDAQ: KMB)
NUS vs KMB Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, KMB has a market cap of 32.3B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while KMB trades at $97.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas KMB's P/E ratio is 13.08. In terms of profitability, NUS's ROE is -0.29%, compared to KMB's ROE of +1.23%. Regarding short-term risk, NUS is more volatile compared to KMB. This indicates higher risk in terms of short-term price fluctuations for NUS.Check KMB's competition here
Church & Dwight Co., Inc. (NYSE: CHD)
NUS vs CHD Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, CHD has a market cap of 22.3B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while CHD trades at $94.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas CHD's P/E ratio is 26.47. In terms of profitability, NUS's ROE is -0.29%, compared to CHD's ROE of +0.18%. Regarding short-term risk, NUS is more volatile compared to CHD. This indicates higher risk in terms of short-term price fluctuations for NUS.Check CHD's competition here
The Clorox Company (NYSE: CLX)
NUS vs CLX Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, CLX has a market cap of 9.8B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while CLX trades at $81.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas CLX's P/E ratio is 14.62. In terms of profitability, NUS's ROE is -0.29%, compared to CLX's ROE of -18.94%. Regarding short-term risk, NUS is more volatile compared to CLX. This indicates higher risk in terms of short-term price fluctuations for NUS.Check CLX's competition here
e.l.f. Beauty, Inc. (NYSE: ELF)
NUS vs ELF Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, ELF has a market cap of 5.9B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while ELF trades at $100.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas ELF's P/E ratio is 25.30. In terms of profitability, NUS's ROE is -0.29%, compared to ELF's ROE of +0.05%. Regarding short-term risk, NUS is more volatile compared to ELF. This indicates higher risk in terms of short-term price fluctuations for NUS.Check ELF's competition here
Reynolds Consumer Products Inc. (NASDAQ: REYN)
NUS vs REYN Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, REYN has a market cap of 4.6B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while REYN trades at $21.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas REYN's P/E ratio is 12.64. In terms of profitability, NUS's ROE is -0.29%, compared to REYN's ROE of +0.15%. Regarding short-term risk, NUS is more volatile compared to REYN. This indicates higher risk in terms of short-term price fluctuations for NUS.Check REYN's competition here
Natura &Co Holding S.A. (NYSE: NTCO)
NUS vs NTCO Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas NTCO's P/E ratio is -11.37. In terms of profitability, NUS's ROE is -0.29%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, NUS is more volatile compared to NTCO. This indicates higher risk in terms of short-term price fluctuations for NUS.Check NTCO's competition here
Inter Parfums, Inc. (NASDAQ: IPAR)
NUS vs IPAR Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, IPAR has a market cap of 3.6B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while IPAR trades at $110.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas IPAR's P/E ratio is 21.22. In terms of profitability, NUS's ROE is -0.29%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, NUS is less volatile compared to IPAR. This indicates lower risk in terms of short-term price fluctuations for NUS.Check IPAR's competition here
Coty Inc. (NYSE: COTY)
NUS vs COTY Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, COTY has a market cap of 2.3B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while COTY trades at $2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas COTY's P/E ratio is 14.44. In terms of profitability, NUS's ROE is -0.29%, compared to COTY's ROE of -0.18%. Regarding short-term risk, NUS is less volatile compared to COTY. This indicates lower risk in terms of short-term price fluctuations for NUS.Check COTY's competition here
Newell Brands Inc. (NASDAQ: NWL)
NUS vs NWL Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, NWL has a market cap of 2.2B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while NWL trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas NWL's P/E ratio is 9.78. In terms of profitability, NUS's ROE is -0.29%, compared to NWL's ROE of -0.09%. Regarding short-term risk, NUS is more volatile compared to NWL. This indicates higher risk in terms of short-term price fluctuations for NUS.Check NWL's competition here
Spectrum Brands Holdings, Inc. (NYSE: SPB)
NUS vs SPB Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, SPB has a market cap of 1.8B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while SPB trades at $79.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas SPB's P/E ratio is 12.23. In terms of profitability, NUS's ROE is -0.29%, compared to SPB's ROE of +0.04%. Regarding short-term risk, NUS is more volatile compared to SPB. This indicates higher risk in terms of short-term price fluctuations for NUS.Check SPB's competition here
Edgewell Personal Care Company (NYSE: EPC)
NUS vs EPC Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, EPC has a market cap of 1.2B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while EPC trades at $26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas EPC's P/E ratio is 14.65. In terms of profitability, NUS's ROE is -0.29%, compared to EPC's ROE of -0.06%. Regarding short-term risk, NUS is less volatile compared to EPC. This indicates lower risk in terms of short-term price fluctuations for NUS.Check EPC's competition here
Oddity Tech Ltd. (NASDAQ: ODD)
NUS vs ODD Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, ODD has a market cap of 1.1B. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while ODD trades at $18.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas ODD's P/E ratio is 14.35. In terms of profitability, NUS's ROE is -0.29%, compared to ODD's ROE of +0.05%. Regarding short-term risk, NUS is less volatile compared to ODD. This indicates lower risk in terms of short-term price fluctuations for NUS.Check ODD's competition here
Helen of Troy Limited (NASDAQ: HELE)
NUS vs HELE Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, HELE has a market cap of 638.4M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while HELE trades at $27.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas HELE's P/E ratio is 8.31. In terms of profitability, NUS's ROE is -0.29%, compared to HELE's ROE of -0.48%. Regarding short-term risk, NUS is less volatile compared to HELE. This indicates lower risk in terms of short-term price fluctuations for NUS.Check HELE's competition here
The Honest Company, Inc. (NASDAQ: HNST)
NUS vs HNST Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, HNST has a market cap of 564.7M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while HNST trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas HNST's P/E ratio is 80.42. In terms of profitability, NUS's ROE is -0.29%, compared to HNST's ROE of -0.07%. Regarding short-term risk, NUS is more volatile compared to HNST. This indicates higher risk in terms of short-term price fluctuations for NUS.Check HNST's competition here
Magnera Corp (NYSE: MAGN)
NUS vs MAGN Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, MAGN has a market cap of 403.3M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while MAGN trades at $11.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas MAGN's P/E ratio is -5.48. In terms of profitability, NUS's ROE is -0.29%, compared to MAGN's ROE of -0.11%. Regarding short-term risk, NUS is less volatile compared to MAGN. This indicates lower risk in terms of short-term price fluctuations for NUS.Check MAGN's competition here
Prenetics Global Limited (NASDAQ: PRE)
NUS vs PRE Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, PRE has a market cap of 393.2M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while PRE trades at $23.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas PRE's P/E ratio is -5.71. In terms of profitability, NUS's ROE is -0.29%, compared to PRE's ROE of -0.49%. Regarding short-term risk, NUS is less volatile compared to PRE. This indicates lower risk in terms of short-term price fluctuations for NUS.Check PRE's competition here
European Wax Center, Inc. (NASDAQ: EWCZ)
NUS vs EWCZ Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while EWCZ trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, NUS's ROE is -0.29%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, NUS is more volatile compared to EWCZ. This indicates higher risk in terms of short-term price fluctuations for NUS.Check EWCZ's competition here
Yatsen Holding Limited (NYSE: YSG)
NUS vs YSG Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, YSG has a market cap of 259.3M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while YSG trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas YSG's P/E ratio is -21.64. In terms of profitability, NUS's ROE is -0.29%, compared to YSG's ROE of -0.07%. Regarding short-term risk, NUS is less volatile compared to YSG. This indicates lower risk in terms of short-term price fluctuations for NUS.Check YSG's competition here
Prenetics Global Limited (NASDAQ: PRENW)
NUS vs PRENW Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, PRENW has a market cap of 250M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while PRENW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas PRENW's P/E ratio is N/A. In terms of profitability, NUS's ROE is -0.29%, compared to PRENW's ROE of -0.49%. Regarding short-term risk, NUS is less volatile compared to PRENW. This indicates lower risk in terms of short-term price fluctuations for NUS.Check PRENW's competition here
Acme United Corporation (AMEX: ACU)
NUS vs ACU Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, ACU has a market cap of 241.5M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while ACU trades at $63.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas ACU's P/E ratio is 27.32. In terms of profitability, NUS's ROE is -0.29%, compared to ACU's ROE of +0.08%. Regarding short-term risk, NUS is more volatile compared to ACU. This indicates higher risk in terms of short-term price fluctuations for NUS.Check ACU's competition here
Pitanium Limited (NASDAQ: PTNM)
NUS vs PTNM Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas PTNM's P/E ratio is 346.33. In terms of profitability, NUS's ROE is -0.29%, compared to PTNM's ROE of -0.99%. Regarding short-term risk, NUS is more volatile compared to PTNM. This indicates higher risk in terms of short-term price fluctuations for NUS.Check PTNM's competition here
Waldencast plc (NASDAQ: WALD)
NUS vs WALD Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, WALD has a market cap of 99.8M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while WALD trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas WALD's P/E ratio is -0.42. In terms of profitability, NUS's ROE is -0.29%, compared to WALD's ROE of -0.48%. Regarding short-term risk, NUS is less volatile compared to WALD. This indicates lower risk in terms of short-term price fluctuations for NUS.Check WALD's competition here
Solesence, Inc. Common Stock (NASDAQ: SLSN)
NUS vs SLSN Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, SLSN has a market cap of 57.9M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while SLSN trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas SLSN's P/E ratio is 66.67. In terms of profitability, NUS's ROE is -0.29%, compared to SLSN's ROE of -0.12%. Regarding short-term risk, NUS is more volatile compared to SLSN. This indicates higher risk in terms of short-term price fluctuations for NUS.Check SLSN's competition here
Grove Collaborative Holdings, Inc. (NYSE: GROV)
NUS vs GROV Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, GROV has a market cap of 44.8M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while GROV trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas GROV's P/E ratio is -5.61. In terms of profitability, NUS's ROE is -0.29%, compared to GROV's ROE of -0.83%. Regarding short-term risk, NUS is less volatile compared to GROV. This indicates lower risk in terms of short-term price fluctuations for NUS.Check GROV's competition here
Axil Brands, Inc. (AMEX: AXIL)
NUS vs AXIL Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, AXIL has a market cap of 41.2M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while AXIL trades at $6.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas AXIL's P/E ratio is 50.33. In terms of profitability, NUS's ROE is -0.29%, compared to AXIL's ROE of +0.24%. Regarding short-term risk, NUS is less volatile compared to AXIL. This indicates lower risk in terms of short-term price fluctuations for NUS.Check AXIL's competition here
United-Guardian, Inc. (NASDAQ: UG)
NUS vs UG Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, UG has a market cap of 32.5M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while UG trades at $7.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas UG's P/E ratio is 13.60. In terms of profitability, NUS's ROE is -0.29%, compared to UG's ROE of +0.22%. Regarding short-term risk, NUS is more volatile compared to UG. This indicates higher risk in terms of short-term price fluctuations for NUS.Check UG's competition here
Waldencast plc (NASDAQ: WALDW)
NUS vs WALDW Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, WALDW has a market cap of 27.4M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while WALDW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas WALDW's P/E ratio is N/A. In terms of profitability, NUS's ROE is -0.29%, compared to WALDW's ROE of -0.48%. Regarding short-term risk, NUS is less volatile compared to WALDW. This indicates lower risk in terms of short-term price fluctuations for NUS.Check WALDW's competition here
Big Tree Cloud Holdings Limited (NASDAQ: DSYWW)
NUS vs DSYWW Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, DSYWW has a market cap of 18.2M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while DSYWW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas DSYWW's P/E ratio is N/A. In terms of profitability, NUS's ROE is -0.29%, compared to DSYWW's ROE of +14.77%. Regarding short-term risk, NUS is more volatile compared to DSYWW. This indicates higher risk in terms of short-term price fluctuations for NUS.Check DSYWW's competition here
Big Tree Cloud Holdings Limited (NASDAQ: DSY)
NUS vs DSY Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, DSY has a market cap of 17.4M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while DSY trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas DSY's P/E ratio is -0.41. In terms of profitability, NUS's ROE is -0.29%, compared to DSY's ROE of +14.77%. Regarding short-term risk, NUS is more volatile compared to DSY. This indicates higher risk in terms of short-term price fluctuations for NUS.Check DSY's competition here
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH)
NUS vs PHH Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while PHH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas PHH's P/E ratio is -0.53. In terms of profitability, NUS's ROE is -0.29%, compared to PHH's ROE of +0.38%. Regarding short-term risk, NUS is less volatile compared to PHH. This indicates lower risk in terms of short-term price fluctuations for NUS.Check PHH's competition here
Tantech Holdings Ltd (NASDAQ: TANH)
NUS vs TANH Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, TANH has a market cap of 9.4M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while TANH trades at $15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas TANH's P/E ratio is 1.60. In terms of profitability, NUS's ROE is -0.29%, compared to TANH's ROE of -0.25%. Regarding short-term risk, NUS is less volatile compared to TANH. This indicates lower risk in terms of short-term price fluctuations for NUS.Check TANH's competition here
Bruush Oral Care Inc. (NASDAQ: BRSH)
NUS vs BRSH Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas BRSH's P/E ratio is -0.01. In terms of profitability, NUS's ROE is -0.29%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, NUS is less volatile compared to BRSH. This indicates lower risk in terms of short-term price fluctuations for NUS.Check BRSH's competition here
Park Ha Biological Technology Co., Ltd. Ordinary Shares (NASDAQ: BYAH)
NUS vs BYAH Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, BYAH has a market cap of 1.7M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while BYAH trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas BYAH's P/E ratio is N/A. In terms of profitability, NUS's ROE is -0.29%, compared to BYAH's ROE of -1.74%. Regarding short-term risk, NUS is less volatile compared to BYAH. This indicates lower risk in terms of short-term price fluctuations for NUS.Check BYAH's competition here
Instinct Bio Technical Co. Holdings Inc. (NASDAQ: BIOT)
NUS vs BIOT Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, BIOT has a market cap of 1.6M. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while BIOT trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas BIOT's P/E ratio is N/A. In terms of profitability, NUS's ROE is -0.29%, compared to BIOT's ROE of -1217.55%. Regarding short-term risk, NUS is less volatile compared to BIOT. This indicates lower risk in terms of short-term price fluctuations for NUS.Check BIOT's competition here
Instinct Bio Technical Company Holdings Inc. Warrants (NASDAQ: BIOTW)
NUS vs BIOTW Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, BIOTW has a market cap of 64.6K. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while BIOTW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas BIOTW's P/E ratio is -0.08. In terms of profitability, NUS's ROE is -0.29%, compared to BIOTW's ROE of -1217.55%. Regarding short-term risk, NUS is less volatile compared to BIOTW. This indicates lower risk in terms of short-term price fluctuations for NUS.Check BIOTW's competition here
Bruush Oral Care Inc. (NASDAQ: BRSHW)
NUS vs BRSHW Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas BRSHW's P/E ratio is N/A. In terms of profitability, NUS's ROE is -0.29%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, NUS is less volatile compared to BRSHW. This indicates lower risk in terms of short-term price fluctuations for NUS.Check BRSHW's competition here
Elizabeth Arden, Inc. (NASDAQ: RDEN)
NUS vs RDEN Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, RDEN has a market cap of 0. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while RDEN trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas RDEN's P/E ratio is -5.68. In terms of profitability, NUS's ROE is -0.29%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, NUS is more volatile compared to RDEN. This indicates higher risk in terms of short-term price fluctuations for NUS.Check RDEN's competition here
Revlon, Inc. (NYSE: REV)
NUS vs REV Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, REV has a market cap of 0. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas REV's P/E ratio is -1.19. In terms of profitability, NUS's ROE is -0.29%, compared to REV's ROE of +0.89%. Regarding short-term risk, NUS is less volatile compared to REV. This indicates lower risk in terms of short-term price fluctuations for NUS.Check REV's competition here
Grove Collaborative Holdings, Inc. (NYSE: GROV-WT)
NUS vs GROV-WT Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while GROV-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, NUS's ROE is -0.29%, compared to GROV-WT's ROE of -0.83%. Regarding short-term risk, NUS is more volatile compared to GROV-WT. This indicates higher risk in terms of short-term price fluctuations for NUS.Check GROV-WT's competition here
Summer Infant, Inc. (NASDAQ: SUMR)
NUS vs SUMR Comparison October 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 219.9M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, NUS is priced at $4.53 on the NYSE, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 3.78, whereas SUMR's P/E ratio is -3.66. In terms of profitability, NUS's ROE is -0.29%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, NUS is more volatile compared to SUMR. This indicates higher risk in terms of short-term price fluctuations for NUS.Check SUMR's competition here